Image 4
Image 4
Image
Image
Image 2
Image 2
Image 3
Image 3
Acute invasive fungal sinusitis is the most aggressive form of fungal sinusitis with 50-80% mortality despite modern management; mortality is higher in diabetic patients often due to delayed presentation
Aspergillus species typically affect neutropenic patients while Zygomycetes (Rhizopus, Mucor, Rhizomucor, Absidia) typically affect diabetic patients, particularly those with ketoacidosis
The infection originates in the nasal cavity (commonly the middle turbinate) and spreads to paranasal sinuses via vascular invasion and bony erosion, potentially extending to orbit, brain, cavernous sinus, or carotid arteries
Vascular invasion is a hallmark feature that distinguishes acute invasive from non-invasive fungal sinusitis, allowing rapid systemic dissemination and life-threatening complications
Early diagnosis and aggressive dual therapy with systemic antifungal agents (amphotericin B) and surgical debridement, combined with correction of underlying immunosuppression, are critical to improving outcomes
Close radiologic surveillance of high-risk immunocompromised patients can detect early disease and reduce mortality to as low as 18%
In an immunocompromised patient with acute sinusitis, always specifically evaluate for periantral fat stranding and check the extent of disease beyond the sinus boundaries (orbit, masticator space, pterygopalatine fossa, cavernous sinus) as these findings significantly impact urgency of management and prognosis; if any concerning features are present, recommend urgent MRI and immediate clinical correlation given the aggressive nature of this condition.